A Microdose Evaluation Study of ABY-029 in Primary Sarcoma
Clinical trial NCT03154411 · COMPLETED
Trial details
- NCT number
- NCT03154411
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-30
- Primary completion
- 2020-12-10
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.